The evolving public perception of obesity stigma reflects a gradual shift toward recognizing obesity as a complex medical condition influenced by biological and environmental factors, rather than a simple matter of personal responsibility
Sobo provides GLP-1 weight loss consultations through Optimal Health Medical in Stamford, Connecticut
American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm 2023 update
3-5 Proposed mechanisms include both intraocular pressure (IOP)lowering effects and IOP-independent effects
Lawsuits allege that Saxenda, like other GLP-1 receptor agonist drugs, has caused serious gastrointestinal injuries, severe vomiting, and increased risk of stomach paralysis
Even as prices come down for GLP-1 weight-loss drugs, much cheaper products marketed as GLP-1 supplements can be alluring to consumers